Recombinant SARS-CoV-2 Spike S1 (D614G) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-COV-2 Spike S1 (D614G) Protein
BS-46010P
ApplicationsWestern Blot, ELISA, Other Application
Product group Proteins / Signaling Molecules
Overview
- SupplierBioss Antibodies
- Product NameRecombinant SARS-COV-2 Spike S1 (D614G) Protein
- Delivery Days Customer16
- ApplicationsWestern Blot, ELISA, Other Application
- CertificationResearch Use Only
- ConjugateUnconjugated
- Estimated Purity>95%
- Scientific DescriptionThe SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
- Storage Instruction-80°C
- UNSPSC12352202